Browsing Over 54 Sessions
Session Type
  • Industry Satellite Symposium
 Filtered By

Sort By
View
Pamplona Auditorium (Hall 2)

Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Ian Chau (Sutton, Surrey, United Kingdom)
Cordoba Auditorium (Hall 7)

F. Hoffmann-La Roche - Multi-disciplinary perspectives on optimising patient outcomes in HER2-positive eBC: Join our MDT and choose your agenda

Date
27.09.2019
Time
18:00 - 19:30
Chairs
  • Giampaolo Bianchini (Milano, Italy)
Malaga Auditorium (Hall 5)

Bristol Myers-Squibb - How immuno-oncology has changed the melanoma treatment landscape

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Eva Muñoz-Couselo (Barcelona, Spain)
Bilbao Auditorium (Hall 5)

Bristol-Myers Squibb - Long-term experience and survival: An overview of I-O therapy in RCC and future research in GU cancers

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Thomas B. Powles (London, United Kingdom)
Tarragona Auditorium (Hall 7)

F. Hoffmann-La Roche - Cracking the code of personalised healthcare

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Arndt Vogel (Hannover, Germany)
Alicante Auditorium (Hall 3)

Pfizer Oncology - Real world data in oncology: Its growing role in research and patient care

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • George D. Demetri (Boston, MA, United States of America)
Cartagena Auditorium (Hall 3)

Merck - Putting immunotherapy into perspective: How should I be treating my SCCHN patients?

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Ezra Cohen (Chicago, IL, United States of America)
Salamanca Auditorium (Hall 3)

Medscape Oncology Global - The challenge of thrombo-inflammation in cancer. The interplay of factors that impact outcome

Date
27.09.2019
Time
18:30 - 20:00
Chairs
  • Paris A. Kosmidis (Marousi, Greece)
  • Agnes Y. Lee (Vancouver, BC, Canada)
Toledo Auditorium (Hall 5)

Fresenius Kabi - Tackling sarcopenia and cachexia: Does it matter for treatment toxicity and overall survival?

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Matti S. Aapro (Genolier, Switzerland)
Oviedo Auditorium (CC5)

Bayer - What potential do TKIs have to optimize outcomes in refractory mCRC and uHCC?

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Eric Van Cutsem (Leuven, Belgium)
Leon Auditorium (Hall 3)

Servier - From trial evidence to clinical practice: Focusing on patients with mGC and mCRC

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Thierry Andre (Paris, France)
  • Fernando Rivera (Santander, Spain)
Santander Auditorium (Hall 3)

Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?

Date
27.09.2019
Time
18:00 - 20:00
Chairs
  • Joaquim Bellmunt (Boston, MA, United States of America)
  • Maria De Santis (Berlin, Germany)